AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Recursion to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 9, 2020 GMT

SALT LAKE CITY--(BUSINESS WIRE)--Jan 9, 2020--

Recursion, a digital biology company industrializing drug discovery, will present a company update at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday January 16 at 10 a.m. PT. Co-founder and CEO Chris Gibson, Ph.D. will provide an overview of Recursion along with an update on recent clinical and corporate milestones.

About Recursion

Recursion is a digital biology company industrializing drug discovery. Recursion does this by combining automation, artificial intelligence, machine learning, in vivo validation capabilities and a highly cross-functional team to discover novel medicines that expand our collective understanding of biology. Recursion’s rich, relatable database of 4 petabytes of biological images generated in-house on the company’s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people’s lives. Recursion is proudly headquartered in Salt Lake City. Learn more at www.recursionpharma.com, or connect on Twitter and LinkedIn.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200109005712/en/

CONTACT: Media Contact:Amanda Guisbond

amanda.guisbond@recursionpharma.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA UTAH

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Recursion

Copyright Business Wire 2020.

PUB: 01/09/2020 12:22 PM/DISC: 01/09/2020 12:22 PM

http://www.businesswire.com/news/home/20200109005712/en